Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
Https://news.yahoo.com/test-prevent-hearing-loss-newborns-061608681.html
Yes, will be interesting trading tomorrow on the back of this news.
At this rate it looks like it's heading back down, but the good thing is the floor will be 5p imo. If sentiment or fundamentals were in play here I'm sure this would have climbed much higher, especially with the volumes we've been getting the last few days. I've been tempted to sell what I used to average down, and try to get in lower but now is not the time, as this could climb some more. It will totally depend on the volumes were getting over the coming days and/or weeks. If volumes continues to be high but the SP doesn't move much then it is for sure heading back down. Only more good news will change that. If there isn't any news and the SP starts to slide I may take that chance. Upcoming trading days will be very interesting and entertaining to watch, certainly brightens up my day.
Holding diffidently.
Of course we're all happy that this has risen and long may it continue, but dont forget it can fall just as fast as it rises. I hope it doesn't fall, but you have to be realistic. Time to think and act with your head, not your emotions.
Almost 13.5M traded today. That could explain why it's gone up. I've always felt the company is undervalued when the MCAP is under 10M. Weve re-rated after todays session so this could be the top for now. It might fall back it might not, but I feel it will come back down then take off again in the new year if there is no further news. I hope I'm wrong but I just have a feeling this is the ceiling for now.
Been here since Jan 2021. Been in and out then got spiked at 150. Been averaging down ever since. I've spent quite a bit here and have managed to average down to 30. I'd be happy to get back half of money which we're not too far off now, but with the fundamentals GDR have I wont be selling any. I see us getting back to at least 50 with AIHL expansion, stroke test, and US market, much higher if all three lands. Too much going on at this company to throw in the towel now or when it hits 30.
I think it's more to do with the annual results. The market is starting to digest the achievements and future prospects of GDR. With another Hospital in Brighton adopting the AIHL, the market is realising that there could be further expansion not just in the UK but also abroad. If things pick up in the USA and EU then the skies the limits. They've also achieved all this thus far without heavy dilution or debt. No matter what people want to say, GDR have done pretty well over the years considering they're a very small company.
Stephen11 - absolutely, tell them again. Sentiment is what really moves AIM stocks. Even sales doesn’t move the stock like sentiment. Hopefully the sentiment will keep up for at least a few more weeks. If it does I’d have got all my investment back and more after having thought I’d lost it all a couple years ago. Fingers and toes all crossed, gla.
Stocksaint - you were hoping to get in at 1p, 2p, or3p yesterday. Bet your feeling sick as a parrot now. If you had bought in yesterday at 5p you’d have almost doubled your money already. Just goes to show you have no idea what your doing. Like many others on here, they just flap their gums in total ignorance. If you knew anything about GDR you would have known that 5p was a bargain price, 1p, 2p, or 3p would have badly undervalued the company. I’m afraid it’s back to school for you lmao. Onwards and Up.
CaptainSwag - Do you not know anything about the company? Latest half year results says we turned over £5M in the first six months alone. Where do you get £1M from? Were on course to turnover 10M this financial year.
GloriaMarket - I wouldn't say it's the end for GDR, they dont have any large debts, only the convertible loans which only affects the value of the shares not our cashflow. With the products the company have, they wont have any problems raising capital with investors.
Yes, it showed that things have improved with the company. Fully expect this to start moving North soon, on the back of some good news which we will receive very soon.
As we announced at the beginning of 2023, FoodPrint® was installed in our first laboratory in the USA and following approvals is now live and actively commercialising FoodPrint®. Further expansion into the USA is planned, with validation and approvals currently taking place with two other laboratories in the region. Could get an update soon which I'm sure will help turn the SP around.
James says that the products we were selling abroad didn't sell because the software and training materials weren't in their local languages. I found that hard to believe, how could the company make such a big error? Did they not sell because of this, or are there other factors in play? Well, he went on to say that now that the product is available in their local languages, sales will start to come through in December. Lets see if the CEO is right or is he going to turn out like that other joker Budd.
Belgrano - Thats a grossly inaccurate statement you just made there. How can you say sales are not increasing? We virtually doubled the turnover we did last year with sales still increasing. I'm happy to see steady growth, its better than no growth at all.
The Board have stated that as well as equity or debt financing they are also actively seeking non-dilutive funding such as grants, and funding partners for the FDA approval. Gdr have a very good track record when it comes to finding other means of financing other than dilution. This is why after so many years in the business, they still have quite a small number of shares in circulation. I don't think we will be seeing any heavy dilution if any at all.
Must say, the Results was very disappointing but the Presentation gave a little hope. Was expecting to hear of increased sales generated from the further rollout in Manchester. The fact that revenue was basically zero, seems like they must be giving the damn thing away. I would have thought a ground-breaking test like the AIHL would have really taken off and be generating decent Sales by now. But by the looks of it, things have been very slow. The Chairman did say in the Presentation that he hopes to be getting good news about the AIHL test in the coming months, but they didn't sound so positive about AIHL in the Annual Report. They hardly mentioned it and when they did all they could says was we are well positioned for expansion. No actual dates or solid news of impending expansions.
The Finances look dire at the moment and they did say that the company will be looking to raise further cash end of Q1 2024. So it could be this drops some more. But on the other hand the Fundamentals are still strong and in place, we still have the AIHL test which could expand exponentially at any given moment, and we also have the stroke test which has just received big funding, and we hope to get some news on that in the coming months. The final NICE recommendation, was expected in December 2023, but that got delayed with further details not yet available. So still lots to look forward to it's just that it looks like this could fall some more before it rises. Hopefully this will happen before any dilution, as the dilution will only hinder how fast and high this rises.
I've been is shares like the old Omega Diagnostics who had the same problem when dealing with the NHS. They move very slow and there's a lot of Beaurocracy, so there's no guarantee AIHL will be rolled out as quickly as we thought. However, we still have the global market to sell to especially now we have facilities setup in USA, any news on that will see this turn around. So all in all, fundamentals are still strong and as we know sentiment alone could raise this to unbelievable heights.
Holding Firmly.